Cargando…
Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning
Background: Markov decision process (MDP) models are powerful tools. They enable the derivation of optimal treatment policies but may incur long computational times and generate decision rules that are challenging to interpret by physicians. Methods: In an effort to improve usability and interpretab...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124941/ https://www.ncbi.nlm.nih.gov/pubmed/30288409 http://dx.doi.org/10.1177/2381468316674214 |
_version_ | 1783353107150798848 |
---|---|
author | Schell, Greggory J. Marrero, Wesley J. Lavieri, Mariel S. Sussman, Jeremy B. Hayward, Rodney A. |
author_facet | Schell, Greggory J. Marrero, Wesley J. Lavieri, Mariel S. Sussman, Jeremy B. Hayward, Rodney A. |
author_sort | Schell, Greggory J. |
collection | PubMed |
description | Background: Markov decision process (MDP) models are powerful tools. They enable the derivation of optimal treatment policies but may incur long computational times and generate decision rules that are challenging to interpret by physicians. Methods: In an effort to improve usability and interpretability, we examined whether Poisson regression can approximate optimal hypertension treatment policies derived by an MDP for maximizing a patient’s expected discounted quality-adjusted life years. Results: We found that our Poisson approximation to the optimal treatment policy matched the optimal policy in 99% of cases. This high accuracy translates to nearly identical health outcomes for patients. Furthermore, the Poisson approximation results in 104 additional quality-adjusted life years per 1000 patients compared to the Seventh Joint National Committee’s treatment guidelines for hypertension. The comparative health performance of the Poisson approximation was robust to the cardiovascular disease risk calculator used and calculator calibration error. Limitations: Our results are based on Markov chain modeling. Conclusions: Poisson model approximation for blood pressure treatment planning has high fidelity to optimal MDP treatment policies, which can improve usability and enhance transparency of more personalized treatment policies. |
format | Online Article Text |
id | pubmed-6124941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-61249412018-10-04 Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning Schell, Greggory J. Marrero, Wesley J. Lavieri, Mariel S. Sussman, Jeremy B. Hayward, Rodney A. MDM Policy Pract Original Article Background: Markov decision process (MDP) models are powerful tools. They enable the derivation of optimal treatment policies but may incur long computational times and generate decision rules that are challenging to interpret by physicians. Methods: In an effort to improve usability and interpretability, we examined whether Poisson regression can approximate optimal hypertension treatment policies derived by an MDP for maximizing a patient’s expected discounted quality-adjusted life years. Results: We found that our Poisson approximation to the optimal treatment policy matched the optimal policy in 99% of cases. This high accuracy translates to nearly identical health outcomes for patients. Furthermore, the Poisson approximation results in 104 additional quality-adjusted life years per 1000 patients compared to the Seventh Joint National Committee’s treatment guidelines for hypertension. The comparative health performance of the Poisson approximation was robust to the cardiovascular disease risk calculator used and calculator calibration error. Limitations: Our results are based on Markov chain modeling. Conclusions: Poisson model approximation for blood pressure treatment planning has high fidelity to optimal MDP treatment policies, which can improve usability and enhance transparency of more personalized treatment policies. SAGE Publications 2016-10-17 /pmc/articles/PMC6124941/ /pubmed/30288409 http://dx.doi.org/10.1177/2381468316674214 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Schell, Greggory J. Marrero, Wesley J. Lavieri, Mariel S. Sussman, Jeremy B. Hayward, Rodney A. Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning |
title | Data-Driven Markov Decision Process Approximations for Personalized
Hypertension Treatment Planning |
title_full | Data-Driven Markov Decision Process Approximations for Personalized
Hypertension Treatment Planning |
title_fullStr | Data-Driven Markov Decision Process Approximations for Personalized
Hypertension Treatment Planning |
title_full_unstemmed | Data-Driven Markov Decision Process Approximations for Personalized
Hypertension Treatment Planning |
title_short | Data-Driven Markov Decision Process Approximations for Personalized
Hypertension Treatment Planning |
title_sort | data-driven markov decision process approximations for personalized
hypertension treatment planning |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124941/ https://www.ncbi.nlm.nih.gov/pubmed/30288409 http://dx.doi.org/10.1177/2381468316674214 |
work_keys_str_mv | AT schellgreggoryj datadrivenmarkovdecisionprocessapproximationsforpersonalizedhypertensiontreatmentplanning AT marrerowesleyj datadrivenmarkovdecisionprocessapproximationsforpersonalizedhypertensiontreatmentplanning AT lavierimariels datadrivenmarkovdecisionprocessapproximationsforpersonalizedhypertensiontreatmentplanning AT sussmanjeremyb datadrivenmarkovdecisionprocessapproximationsforpersonalizedhypertensiontreatmentplanning AT haywardrodneya datadrivenmarkovdecisionprocessapproximationsforpersonalizedhypertensiontreatmentplanning |